Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$16.71 USD
+0.56 (3.47%)
Updated May 10, 2024 04:00 PM ET
After-Market: $16.64 -0.07 (-0.42%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.99 | -27.92% |
Earnings Summary
For their last quarter, Arcus Biosciences (RCUS) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.97 per share. This reflects a positive earnings surprise of 94.85%. Look out for RCUS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.99 per share, reflecting a year-over-year increase of 4.81%.
Earnings History
Price & Consensus
Zacks News for RCUS
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services